This website (this “Site”) is operated by PCG Advisory Inc., and its subsidiaries and affiliates (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this may be ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations thereunder, the “Securities Act”). PCG may be compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

PCG is not registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does PCG engage in any activities that would require such registrations. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client.  No information contained on this Site constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced on this Site. Further, nothing on this Site is intended to provide tax, legal, or investment advice and nothing on this Site should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction.

When used herein, the words “anticipate”, “believe”, “could”, “estimate”, “expect”, “going forward”, “intend”, “may”, “ought to”, “plan”, “project”, “seek”, “should”, “will”, “would” and similar expressions, as they relate to PCG’s clients, are intended to identify forward-looking statements. These forward-looking statements do not reflect PCG’s views or opinions with respect to future events and are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties.

PCG does not verify information provided by clients to PCG. No representation or warranty, express or implied, is made as to the accuracy or completeness of any information contained herein. PCG expressly disclaims any and all liability based, in whole or in part, on such information, any errors therein or omissions therefrom. Additional information about the companies represented on the Site may be found on the websites of the respective companies or, in certain instances, by searching the EDGAR database.


PCG’s research reports, company profiles, videos and other investor relations materials, publications or presentations, including web content and social media posts, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in PCG’s reports, company profiles, videos, or other investor relations materials and presentations are subject to change. PCG and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.

PCG Research is a division of PCG and offers research services to paying clients. PCG Digital is another division of PCG, and offers multimedia services to paying clients, including video presentations, digital publications/articles and interviews. In the purview of Section 17(b) of the Securities Act and in the interest of full disclosure, we call the reader’s attention to the fact that PCG is an investor relations firm hired by certain companies to increase investor awareness to the small-cap equity community.

Because we receive compensation for dissemination of the information about our clients, our publicly disseminated publications should not be regarded in any manner whatsoever as independent. We hereby certify that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed in any reports. Our services and commercial advertisements rendered are not related to, connected to, nor are they contingent on a client’s stock price performance. We are sometimes paid for commercial advertisements and distributions in cash, stock, Rule 144 stock, warrants, options or other securities in lieu of or in addition to our stated compensation schedule. This compensation and ownership of securities of a client’s common stock constitutes a conflict of interest as to our ability to remain objective in our communication regarding our profiled companies. More information can be received from our client company’s website. We may write commercial advertisements or promote a given company on other occasions.

Never base any investment decision on information on this Site or on emails you may receive from PCG.  PCG may have been compensated and our employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies’ profile which is an inherent conflict of interest in our statements and opinions and such statements and opinions cannot be considered independent. PCG and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the applicable company’s profile.  When it comes to buying or selling shares, please assume PCG is buying and/or selling before, during and/or after publication of the discussed company.  We will not advise as to when we decide to buy or sell and do not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Stock market investing is inherently risky. PCG is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission (“SEC”) at www.sec.gov.

Please see below for a list of our 17(b) disclosures in accordance with the SEC rule:

Associates and employees of PCG may, from time to time, trade securities of client companies and companies covered by research published by PCG Research and related publications. Public disclosure, by any means, of future coverage, ratings changes, and/or changes in earnings estimates prior to publication is prohibited.

Please see below for a list of companies which engage PCG Advisory, Inc., and / or any of its affiliates for investor relations and marketing services as described above.


ElectroMedical Technologies, Inc.ELCQ

Abeona Therapeutics, Inc. ABEO
ADGS Advisory, Inc. ADGS
Aditx Therapeutics, Inc. ADTX
AIkido Pharma, Inc. AIKI
Akers Biosciences, Inc. AKER
American Metals Recovery and Recycling Inc. AMRR
American Resources Corporation AREC
American Shared Hospital Services AMS
AmpliTech Group, Inc. AMPR
AnPac Bio-Medical Science Co., Ltd. ANPC
Arch Therapeutics, Inc. ARTH
Asensus Surgical, Inc. ASXC
Auddia, Inc. AUUD
BIGtoken, Inc. FPVD
Bionik Laboratories Corp. BNKL
Blackboxstocks Inc. BLBX
Bubblr Inc. BBLR
Cardax, Inc. CDXI
China United Insurance Group, Inc. CUII
Codex, DNA Inc. DNAY
Eco Innovation Group, Inc. ECOX
Eledon Pharmaceuticals, Inc. ELDN
Emerald Bioscience, Inc. EMBI
Empire Petroleum Corporation EMPR
Exicure, Inc. XCUR
EZRaider Co. EZRG
The Glimpse Group PRIVATE
Gritstone bio, Inc. GRTS
Harbor Custom Development, Inc. HCDI
HealthLynked Corp. HLYK
Hoth Therapautics, Inc. HOTH
Iconic Brands, Inc. ICNB
Kezar Life Sciences, Inc. KZR
Kuuhubb, Inc. KUU.V
Lexaria Bioscience Corp. LXRP
Light Media Holdings, Inc. LGMH
Lipella Pharmaceuticals Inc. LIPO
LiveXLive Media, Inc. LIVX
Mastermind, Inc. MMND
Myomo, Inc. MYO
Natur International Corp. NTUR
Navidea Biopharmaceuticals, Inc. NAVB
Nephros, Inc. NEPH
NextCure, Inc. NXTC
NeuroOne Medical Technologies Corp. NMTC
NewBridge Global Ventures, Inc. NBGV
NightFood Holdings, Inc. NGTF
OpenLocker Holdings, Inc. OLKR
Origin Agritech Limited SEED
Oxford BioDynamics Plc OBD.L
Paltalk, Inc. PALT
PharmaCyte Biotech, Inc. PMCB
ProMIS™ Neurosciences, Inc. PMN
Quoin Pharmaceuticals Ltd. QNRX
Qrons Inc. QRON
RedHawk Holdings Corp. SNDD
Recruiter.com Group, Inc. RCRT
Samsara Luggage, Inc. SAML
Sanuwave Health, Inc. SNWV
SELLAS Life Sciences Group, Inc. SLS
Society Pass Incorporated. PRIVATE
Soligenix, Inc. SNGX
Soluna Holdings, Inc. SLNH
Sono-Tek Corporation SOTK
SS Innovations International SSII
SuperCom Ltd. SPCB
Sustainable Green Team, Ltd. SGTM
Timber Pharmaceuticals, Inc. TMBR
Transportation and Logistics Systems, Inc. TLSS
Verde Bio Holdings, Inc. VBHI
Virios Therapeutics, Inc. VIRI
The Wonderfilm Media Corporation
Zomedica ZOM